A Clinical Trial of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-044)
Clinical trial NCT07776665 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07776665
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2026-12-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.